InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Aguilar Laura K., Directeur Médical. Officer active across 1 companies, notably Candel Therapeutics, Inc.. Aggregated, 3 filings have been published. The latest transaction was disclosed on 6 May 2022 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
€237,339171,335 shares@ €1.38520.077% mcap100.0% of flow
Common Stock
SEC:0000899243-22-017477:0·
56,096 shares
Common Stock
SEC:0000899243-21-031088·
56,096 shares
Common Stock
SEC:0000899243-21-031088:0·
3 of 3 declarations
About Aguilar Laura K.
Aguilar Laura K. is the Chief Medical Officer of Candel Therapeutics, Inc. She is responsible for leading the company's medical and clinical initiatives, bringing her expertise in biotechnology. Her role is crucial for the development of new treatments and therapies.
